| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Molecular Hepatology Laboratory, Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129
Exposure to hepatitis C virus (HCV) is associated with a high prevalence of persistent viral infection and the development of chronic liver disease and hepatocellular carcinoma. Recovery from acute infection may depend upon the generation of broad-based cellular immune responses to viral structural and nonstructural proteins. We used the DNA-based immunization approach in BALB/c mice to determine whether the HCV nonstructural proteins NS3, NS4, and NS5 will induce Ab responses, CD4+ Th cell proliferation, and cytokine release in response to stimulation by recombinant proteins as well as generate CD8+ CTL activity both in vitro and in vivo. We found that the nonstructural proteins were particularly good immunogens and produced cellular immune responses when administered as a DNA construct. Indeed, a tumor model was established following inoculation of syngenic SP2/0 cells stably transfected with NS5. We observed protection against tumor formation and growth only in mice immunized with the NS5-encoding DNA construct, establishing the generation of significant CTL activity in vivo by this technique. The results indicate that genetic immunization may define the cellular immune response of the host to HCV nonstructural proteins and is a promising approach for vaccine development.
This article has been cited by other articles:
|
|
 |
|
  L. Frelin, T. Wahlstrom, A. E. Tucker, J. Jones, J. Hughes, B. O. Lee, J.-N. Billaud, C. Peters, D. Whitacre, D. Peterson, et al. A Mechanism To Explain the Selection of the Hepatitis e Antigen-Negative Mutant during Chronic Hepatitis B Virus Infection J. Virol., February 1, 2009; 83(3): 1379 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gehring, S. H. Gregory, P. Wintermeyer, C. Aloman, and J. R. Wands Generation of Immune Responses against Hepatitis C Virus by Dendritic Cells Containing NS5 Protein-Coated Microparticles Clin. Vaccine Immunol., February 1, 2009; 16(2): 163 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ahlen, J. Soderholm, T. Tjelle, R. Kjeken, L. Frelin, U. Hoglund, P. Blomberg, M. Fons, I. Mathiesen, and M. Sallberg In Vivo Electroporation Enhances the Immunogenicity of Hepatitis C Virus Nonstructural 3/4A DNA by Increased Local DNA Uptake, Protein Expression, Inflammation, and Infiltration of CD3+ T Cells J. Immunol., October 1, 2007; 179(7): 4741 - 4753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Karayiannis, J. Main, and H. C. Thomas Hepatitis vaccines Br. Med. Bull., August 31, 2004; 70(1): 29 - 49. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yu, L. A. Babiuk, and S. van Drunen Littel-van den Hurk Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3 J. Gen. Virol., June 1, 2004; 85(6): 1533 - 1543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Jiao, R. Y.-H. Wang, Q. Qiu, H. J. Alter, and J. W.-K. Shih Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes J. Gen. Virol., June 1, 2004; 85(6): 1545 - 1553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. Simon, K. A. Cornell, T. R. Clark, S. Chou, H. R. Rosen, and R. A. Barry DNA Vaccination Protects Mice against Challenge with Listeria monocytogenes Expressing the Hepatitis C Virus NS3 Protein Infect. Immun., November 1, 2003; 71(11): 6372 - 6380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Lazdina, C. Hultgren, L. Frelin, M. Chen, K. Lodin, O. Weiland, G. Leroux-Roels, J. A. Quiroga, D. L. Peterson, D. R. Milich, et al. Humoral and CD4+ T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein J. Gen. Virol., June 1, 2001; 82(6): 1299 - 1308. [Abstract] [Full Text]
|
|
|
|
|
|
S. Zucchelli, S. Capone, E. Fattori, A. Folgori, A. Di Marco, D. Casimiro, A. J. Simon, R. Laufer, N. La Monica, R. Cortese, et al. Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer J. Virol., December 15, 2000; 74(24): 11598 - 11607. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Arichi, T. Saito, M. E. Major, I. M. Belyakov, M. Shirai, V. H. Engelhard, S. M. Feinstone, and J. A. Berzofsky Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model PNAS, January 4, 2000; 97(1): 297 - 302. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
